Brian Goldstein > Choate, Hall & Stewart > Boston, United States > Lawyer Profile
Choate, Hall & Stewart Offices
TWO INTERNATIONAL PLACE
BOSTON, MA 02110
MASSACHUSETTS
United States
- Firm Profile
- Go to...
Brian Goldstein
Position
Brian Goldstein, co-chair of Choate’s Business & Technology Practice Group, has more than 30 years of experience advising venture capital and growth equity investors and innovative, high-growth companies in health IT, healthcare services, life sciences, and medical device industries, on their most important transactions and helping them to increase the returns on their investments.
Brian regularly advises on financings, strategic partnerships and licensing agreements, mergers and acquisitions, and general business counseling. His international practice includes cross-border financings and acquisitions, as well as advice on other U.S.-based activities, for companies headquartered or with significant operations in the United Kingdom/Ireland, Europe, and Israel.
Brian previously served as Assistant General Counsel at Groundwater Technology, Inc., where he handled SEC reporting; acquisitions, divestitures, and joint ventures; and the sale of a controlling interest of the company to Fluor Daniel.
Brian has advised sophisticated investment funds and globally-recognized investors and companies, including Answers Corp (WebCollage), Bain Capital Life Sciences, Perceptive Advisors (via Perceptive Xontogeny), Shire, and Transformation Capital.
Education
- University of Virginia School of Law
- JD, 1988
- University of Virginia
- BA, 1983, with honors
Lawyer Rankings
United States > M&A/corporate and commercial > Venture capital and emerging companies
Choate, Hall & Stewart serves investors across the investment spectrum, from initial seed and Series A financings to advanced pre-IPO crossover rounds, with clients gaining from the firm’s notable intellectual property expertise. The firm’s investor-side representation includes its support of Bain Capital Life Sciences in the Series C financing of ADARx Pharmaceuticals. In the Boston-based business and technology group, co-chair Brian Goldstein focuses on supporting high-growth entities in the health IT, life sciences, and medical device sectors with financings, licensing agreements, and M&A activities. He shares leadership with John Pitfield, a private equity specialist. Meanwhile, Tobin Sullivan assists clients with venture capital and growth equity financings, corporate governance, and SEC compliance.
Lawyer Rankings
Top Tier Firm Rankings
- Boston Elite > Commercial litigation
- Boston Elite > Corporate & M&A
- Boston Elite > Commercial litigation
Firm Rankings
- Insurance > Advice to insurers
- Boston Elite > Commercial litigation
- Industry focus > Education
- M&A/corporate and commercial > M&A: middle-market (sub-$500m)
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- M&A/corporate and commercial > Venture capital and emerging companies
- Real estate > Real estate
- Finance > Restructuring (including bankruptcy): corporate
- Tax > US taxes: non-contentious